itraconazole has been researched along with Foot Dermatoses in 157 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.64) | 18.7374 |
1990's | 62 (39.49) | 18.2507 |
2000's | 65 (41.40) | 29.6817 |
2010's | 20 (12.74) | 24.3611 |
2020's | 9 (5.73) | 2.80 |
Authors | Studies |
---|---|
Gupta, AK; Talukder, M; Venkataraman, M | 1 |
Abd-Allah, D; Abd-Elhamid, N; Elkholy, B; Nasr, M | 1 |
Lipner, SR; Miller, RC | 1 |
Bamimore, MA; Gupta, AK; Venkataraman, M | 1 |
Rana, D; Rao, BK; Saleem, MA; Shah, RR; Sharif, S; Waqas, N | 1 |
Bonetti, AF; Domingos, EL; Fávero, MLD; Pontarolo, R; Tonin, FS | 1 |
Dyląg, M; Hryncewicz-Gwóźdź, A; Jagielski, T | 1 |
Babaev, M; Daniel, CR; Farhi, R; Foley, KA; Gupta, AK; Kamshov, A; Shemer, A | 1 |
Bei, H; Chen, SP; Fang, Q; Liu, C; Liu, PM; Luo, WX; Wu, YX; Zeng, HY; Zhang, L | 1 |
Barbullushi, A; Dervishi, O; Fida, M; Gjylametaj, N; Kellici, S; Saraceno, R; Vasili, E | 1 |
Foley, KA; Gupta, AK; Mays, RR; Piguet, V; Shear, NH | 1 |
Hamed Khater, M; Khattab, FM | 1 |
Bulger, L; Maddin, S; Quiring, J | 1 |
Hata, Y | 1 |
Sun, PL; Wang, YJ | 1 |
Gunasekara, TA; Nagahawatte, A; Ranawaka, RR | 1 |
Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S | 1 |
de Silva, SH; Gunasekara, TA; Nagahawatte, A; Ranawaka, RR; Weerakoon, HS | 1 |
Rosen, T; Stein Gold, LF | 1 |
Ahmed, SA; Bustamante, B; De Hoog, GS; Seas, C; Van De Sande, WW | 1 |
de Silva, SH; Ranawaka, RR | 1 |
Blandizzi, C; Bresci, F; Del Tacca, M; Di Paolo, M; Guidi, B; Tuccori, M | 1 |
Araiza, J; Bonifaz, A; Cruz, M; De Hoog, S; McGinnis, MR; Mercadillo, P; Rodríguez-Cortés, O; Saúl, A | 1 |
de Silva, N; Ragunathan, RW; Ranawaka, RR | 1 |
Mohagheghzahed, G; Sadighha, A | 1 |
de Berker, D | 1 |
Fan, YM; Huang, WM; Li, W; Zhang, GX | 1 |
Budihardja, D; Freund, V; Mayser, P | 1 |
Mathekga, K; Motswaledi, HM; Nemutavhanani, DL; Sein, PP | 1 |
Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C | 1 |
Piraccini, BM; Sisti, A; Tosti, A | 1 |
Daniel, CR; Jellinek, NJ | 1 |
Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
Iwasaki, T; Kaneshima, T; Kano, R; Namitome, K; Nishifuji, K; Sekiguchi, M | 1 |
Barabino, G; Machetti, M; Parodi, A; Persi, A; Zotti, M | 1 |
Di MartinoOrtiz, B; Rodríguez-Masi, M; Rodríguez-Oviedo, ML | 1 |
Curran, D; Evans, EG; Paul, C; Sigurgeirsson, B | 1 |
Botek, G | 1 |
Amaya, K; Arikian, S; Casciano, J; Doyle, J; Haspel, M; Kahler, K; Shear, N | 1 |
Dowlati, Y; Firooz, A; Khamesipour, A | 1 |
Nagaoka, Y; Okochi, H; Tamaki, K | 1 |
Becker, WH; Choi, SM; de Hoog, GS; Friedrichs, N; Horré, R; Jovanić, B; Marklein, G; Neuhaus, T; Schaal, KP; Schumacher, G | 1 |
Arikan, S; Cetin, ES; Karaarslan, A; Karaarslan, F | 1 |
Biton, A; Chetov, T; Cohen, AD; Medvesovsky, E; Naimer, S; Shai, A; Shalev, R; Vardy, DA | 1 |
Akbar, TM; Aman, S; Haroon, TS; Hussain, I; Jahangir, M | 1 |
Armstrong, D; Bondar, G; Werschler, WP | 1 |
Watanabe, S | 1 |
Lagana, FJ | 1 |
Wenig, JA | 2 |
Joseph, WS | 2 |
Calzada, JM; Cid, A; Fernández, CM; Montero, LA | 1 |
Ben-Ami, R; Brenner, S; Levtov, S; Srebrnik, A | 1 |
Ghilardi, A; Massai, L; Romano, C | 1 |
López-Cepeda, LD; Mora-Ruiz, S; Padilla-Desgarennes, Mdel C; Ramos-Garibay, JA | 1 |
Hattori, N; Li, W; Misawa, Y; Okuzumi, K; Shirai, A; Sugiura, Y; Tamaki, K; Yokoyama, K | 1 |
Carver, SM; Fett, DD; Lederle, FA; Nelson, D; Warshaw, EM; Webster, N; Zielke, GR | 1 |
Arechavala, A; López Daneri, G; Maiolo, E; Negroni, R | 1 |
Hiruma, M | 1 |
Avner, S; Baruch, K; Henri, T; Nir, N | 1 |
Adamski, Z; Maleszka, R | 1 |
Demireli, P; Gündüz, K; Inanir, I; Orgüç, S; Ovali, GY; Sürücüoglu, S | 1 |
Gover, MD; Gupta, AK; Lynde, CW | 1 |
Della-Latta, P; Fox, LP; Geyer, AS; Grossman, ME; Husain, S | 1 |
Sellart-Altisent, M; Torres-Rodríguez, JM | 1 |
Guilhermetti, E; Shinobu, CS; Svidzinski, TI; Takahachi, G | 1 |
Korting, HC; Schmid-Wendtner, MH | 1 |
Ginter-Hanselmayer, G; Smolle, J; Weger, W | 1 |
Hiruma, M; Muto, M; Sugita, T; Takahata, Y | 1 |
Kaplan, B; Nathansohn, N; Shemer, A; Trau, H | 1 |
Maeda, M | 1 |
Bräutigam, M; Nolting, S; Schopf, RE; Weidinger, G | 1 |
Arenas, R; Domínguez-Cherit, J; Fernández, LM | 1 |
de Jonge, K; de Koning, GH; Dekens-Konter, JA; Meyboom, RH; Veentjer, H | 1 |
Andrade, R; Bonifaz, A; Galindo, J; Saúl, A | 1 |
Arikian, SR; Einarson, TR; Kobelt-Nguyen, G; Schubert, F | 1 |
Hay, RJ | 1 |
De Doncker, P; Decroix, J; Dockx, P; Heremans, A; Jacqmin, P; Odds, F; Piérard, GE; Roelant, D; Roseeuw, D; Woestenborghs, R | 1 |
De Doncker, P; Dockx, P; Roseeuw, D; Van Lint, J | 1 |
Bardazzi, F; Colombo, MD; Piraccini, BM; Stinchi, C; Tosti, A; Venturo, N | 1 |
Smith, GN | 1 |
Bergfeld, WF; Bolwell, BJ; Helm, TN; Ruxin, TA; Steck, WD | 1 |
Aly, R; Daniel, CR; Odom, R | 1 |
De Backer, M; De Keyser, P; De Vroey, C; Lesaffre, E | 1 |
Brodell, RT | 1 |
Jones, HE; Zaias, N | 1 |
Fernández-Redondo, V; Ginarte, M; Pereiro, M; Toribio, J | 1 |
Del Rosso, JQ | 1 |
De Doncker, P; Dubois, DJ; Eggleston, A; Gupta, AK; Haneke, E; Tormans, G; Van Doorslaer, EK; Van Rossem, K | 1 |
de Hoog, GS; Gründer, K; Köhn, FM; Mayser, P; Qadripur, S; Schill, WB | 1 |
De Doncker, P; Gupta, AK; Sauder, DN; Scher, RK; Shear, NH | 1 |
Baran, RL; De Doncker, PR; Decroix, J; Degreef, HJ; Gupta, AK; Havu, V; Piérard, GE; Roseeuw, DI; Rosen, T; Scher, RK | 1 |
Brandt, H; Havu, V; Heikkilä, H; Hollmen, A; Oksman, R; Piepponen, T; Rantanen, T; Saari, S; Stubb, S; Turjanmaa, K | 1 |
Bonifaz, A; Carrasco-Gerard, E; Saúl, A | 1 |
Aly, R; Daniel, R; Elewski, BE; Jacko, ML; Jones, HE; Odom, RB; Scher, RK; Zaias, N | 1 |
Hull, PR | 1 |
Epstein, E | 2 |
Doncker, PD; Gupta, AK; Heremans, A; Marynissen, G; Stoffels, P | 1 |
Andersen, W; Kramer, KE; Yaar, M | 1 |
Liao, W; Wen, H; Wu, J | 1 |
Gogate, A; Jerajani, H; Kerkar, P; Padhye, AA; Tendolkar, UM | 1 |
De Doncker, P; Haneke, E; Heremans, A; Tajerbashi, M | 1 |
Elewski, BE | 1 |
Jimenez, T; López-Jodra, O; Madrenys-Brunet, N; Siddat, M; Torres-Rodríguez, JM | 1 |
Colombo, MD; Piraccini, BM; Stinchi, C; Tosti, A | 1 |
Difonzo, EM; Miracco, C; Romano, C | 1 |
Abeck, D; Haneke, E; Ring, J | 1 |
Gupta, AK | 3 |
Evans, EG; Sigurgeirsson, B | 1 |
Ellis, MR; Kane, KY | 1 |
Degreef, H; del Palacio, A; Ginter, G; Mygind, S; Pinto Soares, A; Zuluaga de Cadena, A | 1 |
Matsumoto, T; Nishiyama, S; Tanuma, H | 1 |
Chen, J; Liao, W; Wen, H; Wu, J; Yao, Z | 1 |
Albreski, DA; Gross, EG | 1 |
Church, L; Warrick, D | 1 |
Kejda, J | 1 |
Albreski, DA; Gross, EG; Gupta, AK | 1 |
De Rosso, JQ; Gupta, AK | 2 |
De Doncker, P | 1 |
Gupta, AK; Lambert, J | 1 |
Gupta, AK; Shear, NH | 1 |
De Doncker, P; de Prost, Y; Degreef, H; Delescluse, J; Gupta, AK; Marynissen, G; Nolting, S; Theissen, U; Wallace, R | 1 |
Jain, S; Sehgal, VN | 1 |
Billstein, S; di Fonzo, E; Evans, EG; Goodfield, MJ; Rantanen, T; Ruzicka, T; Sigurgeirsson, B; Vermeer, BJ | 1 |
De Cuyper, C; Hindryckx, PH | 1 |
Cerri, A; Crosti, C; Gianni, C | 1 |
Chong, LY; Ho, HH; Leung, CY; Tang, WY; Wong, TW | 1 |
Adachi, M; Hattori, N; Ichinohe, M; Iozumi, K; Kaneko, T; Shimozuma, M | 1 |
Huang, PH; Paller, AS | 1 |
Bradley, MC; Elewski, BE; Ghannoum, MA; Isham, N; Leidich, S | 1 |
Gupta, AK; Konnikov, N; Lynde, CW | 2 |
Agaoglu, C; Alpay, K; Bahadir, S; Cimsit, G; Inalöz, HS; Parlat, P | 1 |
Adachi, M; Hattori, N; Iozumi, K; Kaneko, T; Shimozuma, M; Tamaki, K | 1 |
Jansen, R; Redekop, WK; Rutten, FF | 1 |
Gregurek-Novak, T; Gupta, AK | 1 |
Khosravi, AR; Mansouri, P | 1 |
Paccagnini, E; Pelliccia, L; Romano, C | 1 |
Difonzo, EM; Paccagnini, E; Romano, C | 1 |
Cardo, PP; Fiallo, P | 1 |
De Doncker, P; Gupta, AK; Haneke, E | 1 |
Lecha, M | 1 |
Adamski, Z; Dworacki, G; Maleszka, R | 1 |
Billstein, S; Evans, EG; Olafsson, JH; Paul, C; Sigurgeirsson, B; Steinsson, JB | 1 |
Heikkilä, H; Stubb, S | 1 |
Cao, C; Wen, H; Yan, L; Zhong, Y | 1 |
Bell-Syer, SE; Brunt, E; Crawford, F; Godfrey, C; Hart, R; Russell, I; Young, P | 1 |
Baran, R | 1 |
Arenas, R; Domínguez, L; Fernández, G | 1 |
Clayton, YM; Hay, RJ; Midgely, G; Moore, MK | 2 |
35 review(s) available for itraconazole and Foot Dermatoses
Article | Year |
---|---|
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Topics: Antifungal Agents; Complementary Therapies; Dermatologic Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Voriconazole | 2022 |
Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta-analysis study.
Topics: Adult; Antifungal Agents; Arthrodermataceae; Bayes Theorem; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Network Meta-Analysis; Onychomycosis; Terbinafine; Treatment Outcome | 2023 |
Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Nails; Network Meta-Analysis; Onychomycosis; Quality of Life; Treatment Outcome | 2022 |
Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Network Meta-Analysis; Onychomycosis; Treatment Outcome | 2020 |
Clinical practice. Fungal nail disease.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Practice Guidelines as Topic; Pyridones; Terbinafine | 2009 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Topics: Adult; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Managed Care Programs; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; United States | 2003 |
Assessing treatment outcomes in toenail onychomycosis clinical trials.
Topics: Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome | 2004 |
Curing onychomycosis: understanding the multitude of variables.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2004 |
The systemic treatment of onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2004 |
The oral antifungal patient.
Topics: Administration, Oral; Antifungal Agents; Contraindications; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Patient Selection; Recurrence; Terbinafine | 2004 |
[Onychomycosis: recent progress in the epidemiology, diagnosis and treatment].
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Risk Factors; Terbinafine | 2006 |
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
Topics: Animals; Antifungal Agents; Fluconazole; Foot Dermatoses; Humans; Immunity, Cellular; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine | 2007 |
A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis.
Topics: Adult; Antifungal Agents; Aspergillus; DNA, Fungal; Female; Foot Dermatoses; Humans; Itraconazole; Microscopy; Naphthalenes; Onychomycosis; Phylogeny; Pulse Therapy, Drug; Sequence Analysis, DNA; Terbinafine; Treatment Failure | 2008 |
The systemic treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Models, Econometric; Naphthalenes; Onychomycosis; State Medicine; Terbinafine | 1994 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconazole; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
Pseudallescheria boydii in an immunocompromised host. Successful treatment with debridement and itraconazole.
Topics: Antifungal Agents; Combined Modality Therapy; Debridement; Foot Dermatoses; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycetoma; Pseudallescheria | 1996 |
Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Tinea Pedis | 1996 |
Onychomycosis--treatment, relapse and re-infection.
Topics: Antifungal Agents; Clinical Trials as Topic; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Prognosis; Recurrence; Terbinafine | 1997 |
Oral treatment options for onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
Topics: Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Drug Monitoring; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Onychomycosis; Remission Induction; Safety; Tinea; Tinea Pedis | 1997 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Nails; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Recurrence; Remission Induction; Terbinafine | 1998 |
Onychomycosis in diabetes. Management considerations.
Topics: Antifungal Agents; Diabetes Complications; Drug Interactions; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
Management of onychomycosis in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; North America; Onychomycosis; Prevalence; Recurrence; Terbinafine | 1999 |
Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Mycoses; Onychomycosis | 1999 |
Itraconazole and terbinafine in perspective: from petri dish to patient.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Foot Dermatoses; Humans; In Vitro Techniques; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis | 1999 |
Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1999 |
The new oral antifungal agents for onychomycosis of the toenails.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
Onychomycosis: treatment perspective.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Ciclopirox; Costs and Cost Analysis; Drug Costs; Economics, Pharmaceutical; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Models, Economic; Naphthalenes; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic; Terbinafine; United States | 2000 |
Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Drug Costs; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; United States | 2002 |
Oral treatments for toenail onychomycosis: a systematic review.
Topics: Administration, Oral; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Onychomycosis; Prognosis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Terbinafine; Treatment Outcome | 2002 |
50 trial(s) available for itraconazole and Foot Dermatoses
Article | Year |
---|---|
Combined long-pulsed Nd-Yag laser and itraconazole versus itraconazole alone in the treatment of onychomycosis nails.
Topics: Adult; Antifungal Agents; Combined Modality Therapy; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Lasers, Solid-State; Male; Middle Aged; Onychomycosis; Patient Satisfaction; Pulse Therapy, Drug; Treatment Outcome | 2020 |
Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis.
Topics: Adult; Antifungal Agents; Capsules; Drug Administration Schedule; Drug Delivery Systems; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Single-Blind Method; Tablets; Treatment Outcome | 2013 |
Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients.
Topics: Adult; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2016 |
Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Logistic Models; Male; Middle Aged; Onychomycosis; Prognosis; Treatment Outcome | 2002 |
Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2003 |
Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Maximum Tolerated Dose; Middle Aged; Onychomycosis; Prospective Studies; Pulse Therapy, Drug; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2003 |
[Optimal dosages and cycles of itraconazole pulse therapy for onychomycosis].
Topics: Antifungal Agents; Double-Blind Method; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Onychomycosis; Pulse Therapy, Drug | 2004 |
A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Dose-Response Relationship, Drug; Female; Foot Dermatoses; Gastrointestinal Diseases; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Patient Dropouts; Pilot Projects; Pruritus; Species Specificity; Terbinafine; Treatment Outcome | 2005 |
Two novel itraconazole pulse therapies for onychomycosis: a 2-year follow-up.
Topics: Administration, Oral; Antifungal Agents; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Pulse Therapy, Drug; Severity of Illness Index; Treatment Outcome | 2006 |
Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Topics: Antifungal Agents; Diabetes Complications; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Pulse Therapy, Drug; Terbinafine; Treatment Outcome | 2006 |
Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
Topics: Adult; Antifungal Agents; Chronic Disease; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Leg; Male; Middle Aged; Nails; Onychomycosis; Prevalence; Treatment Outcome; Venous Insufficiency | 2008 |
Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1995 |
Open randomized comparison of itraconazole versus terbinafine in onychomycosis.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1995 |
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.
Topics: Aged; Analysis of Variance; Antifungal Agents; Chi-Square Distribution; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Nails; Onychomycosis; Trichophyton | 1996 |
Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1995 |
Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Administration Schedule; Drug Tolerance; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Antifungal pulse therapy for onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; HIV Reverse Transcriptase; Humans; Itraconazole; Onychomycosis; RNA-Directed DNA Polymerase; Treatment Outcome | 1996 |
A double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail.
Topics: Adult; Aged; Antifungal Agents; Capsules; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Placebos; Remission Induction | 1996 |
A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
Topics: Administration, Oral; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Capsules; Diarrhea; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Headache; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Placebos; Remission Induction; Rhinitis; Sinusitis; Trichophyton | 1996 |
Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients.
Topics: Antifungal Agents; Drug Administration Schedule; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Treatment Outcome | 1997 |
A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.
Topics: Adolescent; Adult; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1997 |
Itraconazole in onychomycosis: intermittent dose schedule.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis | 1997 |
Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Placebos; Treatment Outcome | 1997 |
Small-dose itraconazole pulse therapy in the treatment of onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1997 |
Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Germany; Hand Dermatoses; Humans; Itraconazole; Male; Miconazole; Middle Aged; Onychomycosis; Treatment Outcome | 1998 |
Safety and efficacy of intermittent therapy with itraconazole in finger- and toenail onychomycosis: a multicentre trial.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1998 |
Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1999 |
Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Dyspepsia; Female; Foot Dermatoses; Headache; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Nausea; Onychomycosis; Taste Disorders; Terbinafine; Treatment Outcome; Trichophyton; Virus Diseases | 1999 |
Clinical and pharmacokinetic investigations of oral intraconazole in the treatment of onychomycosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1999 |
A comparison among four regimens of itraconazole treatment in onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Onychomycosis; Treatment Outcome | 1999 |
The safety of itraconazole in the diabetic population.
Topics: Administration, Oral; Aged; Antifungal Agents; Diabetes Complications; Female; Foot Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Palliative Care | 1999 |
Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
Topics: Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
The use of itraconazole to treat cutaneous fungal infections in children.
Topics: Antifungal Agents; Child; Child, Preschool; Dermatomycoses; Dose-Response Relationship, Drug; Drug Eruptions; Follow-Up Studies; Foot Dermatoses; Gastritis; Headache; Humans; Infant; Itraconazole; Microsporum; Onychomycosis; Patient Dropouts; Skin; Time Factors; Tinea; Tinea Capitis; Tinea Pedis; Treatment Outcome; Trichophyton | 1999 |
L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1999 |
Long-term outcomes in the treatment of toenail onychomycosis.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
Itraconazole pulse therapy for dermatophyte onychomycosis in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Retrospective Studies; Time Factors; Treatment Outcome | 2000 |
Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Terbinafine; Trichophyton | 1999 |
Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Topics: Age Factors; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Patient Compliance; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome | 2001 |
Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome | 2001 |
Continuous terbinafine or pulse itraconazole: a comparative study on onychomycosis.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Topics: Antifungal Agents; Cost-Benefit Analysis; Foot Dermatoses; Humans; Itraconazole; Multicenter Studies as Topic; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine | 2001 |
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Diseases; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Mitosporic Fungi; Naphthalenes; Nausea; Onychomycosis; Photosensitivity Disorders; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome; Vomiting | 2001 |
Age as limiting factor of the efficacy of itraconazole for treatment of onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2001 |
Itraconazole pulse therapy for the treatment of Candida onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug; Treatment Outcome | 2001 |
Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drug Costs; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Morpholines; Onychomycosis; Treatment Outcome; Trichophyton | 2001 |
Evaluation of lymphocytes subpopulations and natural killer cells in peripheral blood of patients treated for dermatophyte onychomycosis.
Topics: Antifungal Agents; Antigens, CD19; CD3 Complex; CD4 Antigens; Epidermophyton; Foot Dermatoses; Hand Dermatoses; HLA-DR Antigens; Humans; Itraconazole; Killer Cells, Natural; Lymphocyte Count; Lymphocyte Subsets; Naphthalenes; Onychomycosis; Salicylates; Terbinafine; Trichophyton | 2001 |
Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Longitudinal Studies; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Retreatment; Terbinafine; Tinea; Treatment Outcome; Trichophyton | 2002 |
Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2002 |
Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent.
Topics: Administration, Topical; Adult; Antifungal Agents; Drug Therapy, Combination; Emollients; Female; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Keratolytic Agents; Ketoconazole; Male; Middle Aged; Onychomycosis; Prospective Studies | 1991 |
72 other study(ies) available for itraconazole and Foot Dermatoses
Article | Year |
---|---|
Acitretin: Could it be a new therapeutic player in the field of onychomycosis?
Topics: Acitretin; Adult; Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Treatment Outcome | 2022 |
Distinct patient characteristics and pathogenesis of fingernail only vs. fingernail and toenail onychomycosis in a retrospective single-centre academic study.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Nails; Onychomycosis; Retrospective Studies | 2023 |
Review of treatments for toenail onychomycosis caused by dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Foot Dermatoses; Humans; Itraconazole; Nails; Onychomycosis | 2023 |
Comparing the Efficacy for Pulse Versus Continuous Dose Terbinafine Therapy in Patients With Onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2023 |
Onychomycosis Due to Arthrinium arundinis: A Case Report.
Topics: Adult; Antifungal Agents; Ascomycota; Drug Therapy, Combination; Foot Dermatoses; Humans; Itraconazole; Male; Microscopy, Electron, Scanning; Morpholines; Onychomycosis; Remission Induction; Treatment Outcome | 2017 |
Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Retrospective Studies; Secondary Prevention; Terbinafine | 2017 |
The Energy Density and Treatment Times Are the Main Factors That Affect the Efficacy of Long-Pulsed 1,064-nm Nd:YAG Laser Treatment for Onychomycosis Caused by Trichophyton rubrum.
Topics: Adolescent; Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Lasers, Solid-State; Low-Level Light Therapy; Male; Middle Aged; Onychomycosis; Treatment Outcome; Trichophyton; Young Adult | 2018 |
Eumycetoma pedis in an Albanian farmer.
Topics: Antifungal Agents; Diagnosis, Differential; Farmers; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Madurella; Male; Middle Aged; Mycetoma | 2018 |
[Photo quiz: Dermatomycosis].
Topics: Administration, Oral; Antifungal Agents; Candida albicans; Candidiasis, Cutaneous; Diagnostic Errors; Female; Foot Dermatoses; Humans; Itraconazole; Microscopy; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Failure; Treatment Outcome | 2013 |
Fungal melanonychia caused by Trichophyton rubrum and the value of dermoscopy.
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Dermoscopy; Diagnosis, Differential; Foot Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Pigmentation; Trichophyton | 2014 |
Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
Topics: Adult; Aged; Antifungal Agents; Female; Foot Dermatoses; Fusariosis; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Paronychia; Recurrence; Terbinafine; Treatment Outcome | 2015 |
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic Errors; Foot Dermatoses; Humans; Immunohistochemistry; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Radiography; Scedosporium; Subcutaneous Tissue; Sudan; Voriconazole | 2015 |
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States | 2016 |
Phaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma.
Topics: Adult; Antifungal Agents; Ascomycota; Biopsy, Needle; Follow-Up Studies; Foot Dermatoses; Humans; Immunohistochemistry; Itraconazole; Male; Mycetoma; Severity of Illness Index; Treatment Outcome | 2016 |
Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Detergents; Diabetes Complications; Eczema; Female; Foot Dermatoses; Fusariosis; Hand Dermatoses; Humans; Hypertension; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Paronychia; Risk Factors; Soil; Terbinafine; Time-to-Treatment; Treatment Outcome; Water; Young Adult | 2017 |
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis.
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Foot Dermatoses; Humans; Itraconazole; Middle Aged; Onychomycosis | 2008 |
Eumycetoma caused by Cladophialophora bantiana successfully treated with itraconazole.
Topics: Antifungal Agents; Ascomycota; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Mycetoma; Treatment Outcome | 2009 |
Onychomycosis caused by Fusarium sp in Sri Lanka: prevalence, clinical features and response to itraconazole pulse therapy in six cases.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Prevalence; Sri Lanka | 2008 |
Onychomycosis: report on experience with itraconazole in 37 patients aged older than 50 years: a multivariate regression.
Topics: Aged; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Multivariate Analysis; Onychomycosis | 2009 |
Onychomycosis caused by Nigrospora sphaerica in an immunocompetent man.
Topics: Antifungal Agents; DNA, Fungal; Foot Dermatoses; Humans; Immunocompetence; Itraconazole; Male; Mitosporic Fungi; Onychomycosis; Sequence Analysis, DNA; Young Adult | 2009 |
Paecilomyces lilacinus eumycetoma.
Topics: Antifungal Agents; Biopsy; Dermatomycoses; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Mycetoma; Paecilomyces; South Africa | 2009 |
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine | 2010 |
Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
Topics: Adult; Aged; Antifungal Agents; Arthrodermataceae; Female; Foot Dermatoses; Humans; Itraconazole; Lacquer; Male; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Treatment Outcome | 2010 |
Commentary: the illusory tinea unguium cure.
Topics: Aged; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Trichophyton | 2010 |
Isolation of Fusarium sp. from a claw of a dog with onychomycosis.
Topics: Animals; Antifungal Agents; Base Sequence; DNA, Fungal; DNA, Ribosomal Spacer; Dog Diseases; Dogs; Foot Dermatoses; Fusariosis; Fusarium; Histocytochemistry; Hoof and Claw; Itraconazole; Male; Molecular Sequence Data; Onychomycosis; Polymerase Chain Reaction | 2011 |
Onychomycosis: first case due to Aspergillus nomius.
Topics: Administration, Oral; Antifungal Agents; Aspergillus; Female; Foot Dermatoses; Humans; Itraconazole; Middle Aged; Onychomycosis; Treatment Outcome | 2011 |
Chronic multifocal paracoccidioidomycosis in an immunocompetent adult.
Topics: Antifungal Agents; Chronic Disease; Facial Dermatoses; Foot Dermatoses; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Lip Diseases; Male; Middle Aged; Paracoccidioides; Paracoccidioidomycosis; Paraguay; Skin Ulcer | 2012 |
Fungal nail infection: assessing the new treatment options.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Immunocompromised Host; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
Leukocytopenia after administration of itraconazole.
Topics: Adolescent; Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Leukopenia; Male; Tinea; Trichophyton | 2003 |
Fatal pulmonary scedosporiosis.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Dermatomycoses; Fatal Outcome; Female; Foot Dermatoses; Germany; Humans; Itraconazole; Lung Diseases, Fungal; Pneumonia; Renal Insufficiency; Respiration, Artificial; Scedosporium; Shock, Septic; Toes | 2003 |
Skin infection caused by Scedosporium apiospermum.
Topics: Adult; Amphotericin B; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Scedosporium; Terbinafine | 2003 |
An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Probability; Pulse Therapy, Drug; Retrospective Studies; Severity of Illness Index; Sex Factors; Terbinafine; Treatment Outcome | 2003 |
[Nodular lesions of the posterior foot in a renal transplant patient].
Topics: Antifungal Agents; Combined Modality Therapy; Debridement; Foot Dermatoses; Humans; Immunocompromised Host; Itraconazole; Kidney Transplantation; Male; Middle Aged; Mycetoma; Postoperative Complications; Scedosporium | 2004 |
Liver failure and transplantation after itraconazole treatment for toenail onychomycosis.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Liver Failure; Liver Function Tests; Liver Transplantation; Onychomycosis | 2005 |
Subungual hyperkeratosis of the big toe due to Bipolaris hawaiiensis.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Keratosis; Mitosporic Fungi; Onychomycosis | 2004 |
Small eumycetic mycetoma due to black grain.
Topics: Aged; Agriculture; Biopsy, Needle; Edible Grain; Follow-Up Studies; Foot Dermatoses; Humans; Immunohistochemistry; Itraconazole; Male; Mycetoma; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Onychomycosis caused by Fusarium proliferatum.
Topics: Antifungal Agents; Foot Dermatoses; Fusarium; Genes, Fungal; Hand Dermatoses; Humans; Itraconazole; Japan; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug; Sequence Analysis, DNA | 2005 |
[Clinical cases in medical mycology. Case No. 19].
Topics: Adult; Antifungal Agents; Arthritis, Infectious; Foot Dermatoses; Humans; Itraconazole; Madurella; Magnetic Resonance Imaging; Male; Mycetoma; Osteitis; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
[The treatment of extensive onychomycosis in aged patients].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Morpholines; Nails; Onychomycosis; Treatment Outcome | 2001 |
A case of mycetoma successfully treated with itraconazole and co-trimoxazole.
Topics: Adult; Anti-Infective Agents; Antifungal Agents; Female; Foot Dermatoses; Fungi; Humans; Hyphae; Itraconazole; Magnetic Resonance Imaging; Microscopy; Mycetoma; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Acremonium mycetoma in a heart transplant recipient.
Topics: Acremonium; Antifungal Agents; Cardiomyopathy, Dilated; Foot Dermatoses; Gambia; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Mycetoma; Postoperative Complications | 2006 |
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole | 2006 |
Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Immunocompetence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2007 |
Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2008 |
Itraconazole concentrations of fingernails and toenails of patients with tinea unguium.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Onychomycosis | 2008 |
[Potentiation of digoxin by itraconazole].
Topics: Aged; Candidiasis, Cutaneous; Digoxin; Drug Synergism; Female; Foot Dermatoses; Humans; Itraconazole | 1994 |
Primary cutaneous coccidioidomycosis treated with itraconazole.
Topics: Adult; Coccidioidomycosis; Diagnosis, Differential; Follow-Up Studies; Foot Dermatoses; Foot Diseases; Humans; Impetigo; Itraconazole; Leg Dermatoses; Male; Warts | 1994 |
Ethics and micromanaged care.
Topics: Antifungal Agents; Dermatology; Disclosure; Ethics, Medical; Foot Dermatoses; Humans; Itraconazole; Male; Managed Care Programs; Middle Aged; Onychomycosis; Risk Assessment; Tinea Pedis; United States | 1996 |
Plantar infection by Scopulariopsis brevicaulis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Erythema; Female; Foot Dermatoses; Humans; Imidazoles; Itraconazole; Mitosporic Fungi; Naphthalenes; Onychomycosis; Pruritus; Recurrence; Terbinafine | 1996 |
Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Topics: Algorithms; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Trees; Drug Administration Schedule; Drug Costs; Evaluation Studies as Topic; Follow-Up Studies; Foot Dermatoses; Germany; Health Resources; Humans; Itraconazole; Meta-Analysis as Topic; Naphthalenes; Onychomycosis; Paint; Practice Patterns, Physicians'; Pyridones; Sensitivity and Specificity; Terbinafine | 1996 |
[Diagnosis, clinical aspects and therapy of early chromoblastomycosis in a case example].
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Chromoblastomycosis; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Phialophora; Recurrence | 1996 |
Onychomycosis. New therapies for an old disease.
Topics: Aged; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 1996 |
Onychomycosis--a different perspective.
Topics: Antifungal Agents; Arthrodermataceae; Cost-Benefit Analysis; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Recurrence; Terbinafine | 1997 |
Purpuric drug eruption secondary to itraconazole.
Topics: Aged; Antifungal Agents; Drug Eruptions; Erythema; Female; Foot Dermatoses; Humans; Hyperpigmentation; Itraconazole; Onychomycosis; Purpura | 1997 |
Phaeohyphomycotic ulcer caused by Phialophora verrucosa: successful treatment with itraconazole.
Topics: Antifungal Agents; Dermatomycoses; Female; Foot Dermatoses; Humans; Itraconazole; Leg Ulcer; Middle Aged; Phialophora; Treatment Outcome | 1998 |
Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Female; Foot Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Spain; Terbinafine | 1998 |
Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
Topics: Antifungal Agents; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Recurrence; Terbinafine; Time Factors; Tinea; Tinea Pedis; Toes; Trichophyton | 1998 |
Skin and nail infections due to Fusarium oxysporum in Tuscany, Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Dermatomycoses; Foot Dermatoses; Fusarium; Humans; Intertrigo; Itraconazole; Male; Microscopy, Electron, Scanning; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Topics: Antifungal Agents; Costs and Cost Analysis; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1998 |
Oral treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Reproducibility of Results; Terbinafine; Treatment Outcome | 1999 |
Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Multicenter Studies as Topic; Naphthalenes; Onychomycosis; Prospective Studies; Randomized Controlled Trials as Topic; Terbinafine; Treatment Outcome | 1999 |
Non-dermatophytic onychomycosis. An understimated entity? A study of 51 cases.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Intermittent pulse therapy with itraconazole for onychomycosis. Experience in Hong Kong Chinese.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Hand Dermatoses; Hong Kong; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2000 |
Case report. Onychomycosis due to Chaetomium globosum successfully treated with itraconazole.
Topics: Antifungal Agents; Chaetomium; Foot Dermatoses; Humans; Itraconazole; Japan; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2000 |
Long-term follow-up study of onychomycosis: cure rate and dropout rate with oral antifungal treatments.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Female; Follow-Up Studies; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Regression Analysis; Retrospective Studies; Treatment Outcome | 2001 |
Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Candida; Child; Dermatomycoses; Female; Foot Dermatoses; Hand Dermatoses; Humans; Iran; Itraconazole; Male; Middle Aged; Onychomycosis; Trichophyton | 2001 |
Case report. Onychomycosis due to Microsporum canis.
Topics: Aged; Animals; Antifungal Agents; Asthma; Carrier State; Cat Diseases; Cats; Foot Dermatoses; Hair; Humans; Itraconazole; Male; Microsporum; Onychomycosis; Pulse Therapy, Drug | 2001 |
Onychomycosis caused by Alternaria spp. in Tuscany, Italy from 1985 to 1999.
Topics: Aged; Alternaria; Antifungal Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Italy; Itraconazole; Keratosis; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2001 |
[Intermittent-pulse treatment of onychomycosis with orally administered itraconazole].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug | 1999 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones | 1992 |
Itraconazole in the management of chronic dermatophytosis.
Topics: Adult; Aged; Antifungal Agents; Chronic Disease; Dermatomycoses; Drug Administration Schedule; Female; Fingers; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Toes | 1990 |
An evaluation of itraconazole in the management of onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Drug Evaluation; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Onychomycosis | 1988 |